The study is a single-blind clinical trial in which block randomization will be used for the allocation of subjects, and the patients will be unaware of the type of intervention.
This research will be conducted on patients undergoing coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB) at Shahid Rajaei Cardiovascular, Medical, Research, and Training Center in the year 2025 (1404 Iranian calendar).
Data will be collected using data collection forms (attached) containing clinical information extracted from patients’ medical records, including name, surname, age, sex, height, weight, diagnosis, type of surgery, attending physician and surgeon, as well as clinical outcome results.
To identify eligible participants, the researcher will obtain a list of medical records of patients scheduled for Tetralogy of Fallot surgery from the relevant department heads. Then, based on a review of these medical records, patients who meet the inclusion criteria will be continuously recruited as study samples.